|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||35.81 - 36.21|
|52 Week Range||29.83 - 36.21|
|PE Ratio (TTM)||26.33|
|Dividend & Yield||1.28 (3.62%)|
|1y Target Est||N/A|
Pfizer has filed a suit against Johnson & Johnson alleging that it has engaged in anticompetitive behavior to block market demand for Pfizer's Remicade biosimilar.
The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...
Pfizer filed suit against Johnson & Johnson alleging it has thwarted competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced ...